KR20190037856A - Therapeutic device for reducing the bioelectric potential of a target region - Google Patents

Abstract

The treatment device for reducing the bioelectrical potential of the target site may include an electrode attached to the body surface of the target site and a bioelectric potential reduction unit for reducing the bioelectric potential of the target site by receiving the charge through the electrode.

Description

[0001] THERAPEUTIC DEVICE FOR REDUCING THE BIOELECTRIC POTENTIAL OF A TARGET REGION [0002]

The present invention relates to a therapeutic device for reducing the bio-potential of a target site.

In general, according to the Oriental disease view, the human body has a book (臟 腑, five large body), and if the functions of these books are harmonized with each other, it is healthy, and if the harmony of books is scattered, .

The control of function of this book is made by the energy circulation system (circulatory system - flow of 气 and blood, or meridian) which passes the inside and outside of the body from the head to the leg and from the chest to the arm.

There are sixteen canons (liver, heart, spleen, lung, kidney, heart) and six pieces of meat (膽, small intestine, stomach, large intestine, bladder, There are two kinds of pagodas.

Acupuncture refers to a place where energy flows around a meridian, which is a flow chart of the body, and a place where it is easy to get rid of. If you choose the acupuncture point of each meridian and eliminate energy stopping or stopping, the flow of meridians is improved and the function of the book is also harmonized correctly. However, acupuncture points and meridians are not equally regularly arranged on the surface or muscles of the body regularly, so it is important to find accurate acupuncture points and meridians for each individual.

In the traditional way to find acupuncture points, acupuncture points of acupuncture points, acupuncture points, acupuncture points, coldness, swelling, small points and skin patches are seen on acupressure.

In addition, there is a place where an unpleasant sensation always appears in a certain area when the body is sick, and this is called a tender point. The tender point is tenderness in the acupuncture point where the flow of the flow is blocked, and there is a way to find the acupuncture point and to find the acupuncture point.

However, the traditional way to rely on the feelings of each individual who is treating the doctors to the gauge, the position of the acupuncture point is wrong and can not find the exact acupoint.

In recent years, various scientific studies and research methods for acupuncture points and meridians have been studied. The meridian hypothesis on the meridian which has been published so far includes the vasculature function, neuro - body fluid function theory, bio control system theory, Structure. Among these, the most popular theory is the vascular function theory which explains the function of the microcirculatory system of cardiovascular pain.

On the other hand, it is known that a body current is generated in our body and circulates the whole body. There is a region of low resistance and high potential in the human body. This particular cell group has a variable cell membrane potential and has a special structure and function. The fluctuating cell membrane potential is the bioelectrical charge and the area where the bioelectronic charge is large is the acupuncture point. That is, since the cell membrane potential is actively shifted compared to the non-acupuncture site, the capacitance component value is large, whereas the resistance component value is small.

As a conventional method for identifying acupuncture points, direct skin stimulation such as DC stimulation, high frequency square wave stimulation, and high frequency low frequency impulse stimulation was applied to the skin to measure the resistance of the skin, thereby identifying acupuncture points. However, by applying an artificial electrical stimulation to the human body, it has been difficult to accurately measure the physiological changes such as cell polarization, repolarization and depolarization by applying the electrical stimulation to the human body. In addition, the skin impedance is greatly changed according to the wetness condition of the skin, I had trouble finding it.

The background technology of the present application is disclosed in Korean Patent Registration No. 10-1004373 (Registered on December 21, 2010).

It is an object of the present invention to provide a therapeutic apparatus capable of providing a therapeutic effect by attaching an electrode to a body surface of a target site and reducing a bioelectric potential of a target site.

It is an object of the present invention to provide a treatment device capable of measuring a bioelectrical charge to determine a point of acupoint and decreasing a bioelectrical potential of a corresponding acupoint to provide a therapeutic effect.

In order to solve the problems of the prior art described above, in the method of measuring the menstrual blood, the electrode is minimally contacted with the body, and the menstrual blood is measured irrespective of the dry and wet condition of the skin, And to provide a therapeutic device that can be used.

It should be understood, however, that the technical scope of the embodiments of the present invention is not limited to the above-described technical problems, and other technical problems may exist.

According to an aspect of the present invention, there is provided a treatment apparatus for reducing a bioelectrical potential of a target site, comprising: an electrode attached to a body surface of a target site; And a bio-potential reduction unit for reducing the bio-potential of the target site.

According to one embodiment of the present application, the bio-potential decreasing section generates a first potential difference associated with a first living body potential by charging and discharging the electric charge in a first time interval, and charges and discharges the electric charge in a second time interval And the second time interval is a time interval after the first time interval, and the second potential difference may be smaller than the first potential difference.

According to an embodiment of the present invention, the bio-potential reduction unit further includes a disease-related numerical value detection unit for detecting a disease-related numerical value of a subject, wherein the second disease-related value detected after the second time interval is the first time- May be different from the first disease-related value detected after the interval.

According to one embodiment of the present application, the bio-potential decreasing section generates a third potential difference related to a third living body potential by charging and discharging the electric charge in a third time interval, the first time interval corresponding to one rotation , The second time interval corresponds to an N number of times (N is a natural number greater than 1), the third time interval corresponds to an M number of times (where M is a natural number greater than N) It may be the same as the second potential difference.

According to an embodiment of the present invention, the target portion is a first target portion, the bioelectrical potential is a first bio potential, and the bioelectrical potential decreasing portion is configured to charge and discharge the charge N times (where N is a natural number greater than 1) By discharging the first living body potential to the first target living body potential of the first target site.

According to an embodiment of the present invention, when the target site is the second target site, the bio-potential decreasing unit charges and discharges the charge of M times (where M is a natural number different from 1 and a natural number different from N) And to decrease the second biological potential of the second target site to the second target biological potential of the second target site.

According to an embodiment of the present invention, a treatment apparatus includes an input unit that receives selection information of the first target site or a second target site through a user interface, and a control unit that controls the operation of the living body potential reduction unit based on the selection information .

According to an embodiment of the present invention, the selection information input via the user interface includes at least one of the information on N, the information on M, the first target vital potential and the second target vital potential .

According to one embodiment of the present invention, the treatment apparatus may further include an input unit for receiving selection information through a user interface, and a control unit for controlling the operation of the living body potential decreasing unit based on the selection information.

According to an embodiment of the present invention, the input unit receives the selection information of the first target region through a user interface, the control unit determines operation information based on the selection information, It is possible to control the operation of the living body potential decreasing section.

According to one embodiment of the present invention, the operation information may include at least one of the information on N, the first target vital potential, the time interval per one time, the charge time, the discharge time, the capacitor selection information, and the switching speed .

According to an embodiment of the present invention, the bio-potential reduction unit includes: a switching unit for switching ON or OFF of a connection between the electrode and the capacitor; a charging unit for receiving charge through the electrode when the connection is ON; And a discharge unit for discharging the charge of the charged capacitor when the connection is turned off, wherein the treatment apparatus further includes a control unit for controlling the operation of the living body potential decreasing unit.

According to an embodiment of the present invention, the treatment apparatus may be such that the amount of ions distributed in the target site is decreased due to the reduction of the bio-potential.

According to an embodiment of the present invention, the capacitor is a variable capacitor, and the capacitance of the variable capacitor can be determined based on a control signal of the control unit.

According to one embodiment of the present invention, the variable capacitor may vary within a range of 0.1 uF to 0.33 uF.

According to an embodiment of the present invention, a treatment apparatus includes a signal preprocessing unit for amplifying a bio-potential signal received from the bio-potential decreasing unit to remove noise, a bio-potential generating unit for converting the bio-potential signal received from the signal preprocessing unit into a digital signal And an arithmetic processing unit for calculating the bio-potential signal received from the A / D conversion unit and the A / D conversion unit to determine whether it is menstrual or non-menstrual.

According to one embodiment of the present invention, the control unit determines operation information of the living body potential decreasing unit based on the determination result of the menstrual flow and the non-acupuncture of the operation processing unit, and controls the operation of the living body potential decreasing unit based on the operation information Can be controlled.

According to an embodiment of the present invention, when the calculation result of at least one of the plurality of points is a menstrual discharge, the arithmetic processing unit may generate a control signal and transmit the control signal to the switch unit.

According to one embodiment of the invention, the treatment device may include a housing formed to be attachable to the body of the user.

According to an embodiment of the present invention, a plurality of electrodes are attached to a body surface of a target site, the control unit determines operation information on each of the plurality of electrodes, and based on the operation information, Can be controlled.

According to an embodiment of the present invention, there is provided a biometric information display apparatus, including a data generating unit for generating bio-potential information of a target site measured for a preset time, wherein the data generating unit graphs the bio- .

According to an embodiment of the present invention, the treatment apparatus may further include a transmitter for transmitting the bioelectrical potential change value of the data generator to the user terminal.

According to an embodiment of the present invention, there is provided a method of reducing a bioelectrical potential of a target site, the method comprising: receiving charges through electrodes attached to a body surface of a target site, RTI ID = 0.0 > vivo < / RTI >

According to an embodiment of the present invention, the step of reducing the bioelectrical potential of the target site may include switching the ON or OFF of the connection between the electrode and the capacitor in the switching unit, Charging by receiving charge through the electrode; Discharging the charge of the charged capacitor when the connection is turned off at the discharging part, and controlling the operation of the living body potential reducing part at the controlling part.

The above-described task solution is merely exemplary and should not be construed as limiting the present disclosure. In addition to the exemplary embodiments described above, there may be additional embodiments in the drawings and the detailed description of the invention.

According to the above-mentioned problem solving means of the present invention, it is possible to provide a treatment apparatus capable of applying an electrode to a body surface of a target site and reducing a living body potential of a target site to provide a therapeutic effect.

In order to solve the problems of the conventional art described above, it is possible to provide a therapeutic effect by measuring the bioelectrical charge by charging and discharging the bioelectrical charge amount, determining the acupoint point, and decreasing the bioelectrical potential of the acupuncture point.

In order to solve the problems of the prior art described above, in the method of measuring the menstrual blood, the electrode is minimally contacted with the body, and the menstrual blood is measured irrespective of the dry and wet condition of the skin, Which can provide a therapeutic device that can be used.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic view showing a configuration of a treatment apparatus according to an embodiment of the present invention; FIG.
2 is a block diagram schematically showing a configuration of a treatment apparatus according to an embodiment of the present invention.
3 is a diagram for explaining a relationship between a capacitor and a resistance at a target site or a non-target site according to an embodiment of the present invention.
4 is a diagram for explaining charging and discharging of a bioelectrical charge in the bioelectrical potential decreasing part according to one embodiment of the present invention.
FIG. 5 is a diagram schematically illustrating the operation of a treatment apparatus according to an embodiment of the present invention; FIG.
6 is a view showing an example of a case where a plurality of treatment apparatuses according to an embodiment of the present application are provided.
FIG. 7 is an exemplary diagram illustrating an example in which a result of a treatment apparatus according to an embodiment of the present invention is dataized and provided to a user.
FIG. 8 is a graphical representation of the progress of the reduction of the bioelectrical potential at the target site according to the embodiment of the present invention.

Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those skilled in the art can easily carry out the present invention. It should be understood, however, that the present invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. In the drawings, the same reference numbers are used throughout the specification to refer to the same or like parts.

Throughout this specification, when a part is referred to as being "connected" to another part, it is not limited to a case where it is "directly connected" but also includes the case where it is "electrically connected" do.

It will be appreciated that throughout the specification it will be understood that when a member is located on another member "top", "top", "under", "bottom" But also the case where there is another member between the two members as well as the case where they are in contact with each other.

Throughout this specification, when an element is referred to as "including " an element, it is understood that the element may include other elements as well, without departing from the other elements unless specifically stated otherwise.

The present invention relates to a therapeutic apparatus and a method for reducing a bio-potential of a target site.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic diagram showing the configuration of a treatment system according to an embodiment of the present invention; FIG.

Referring to FIG. 1, a treatment system according to an embodiment of the present invention may include a treatment device 100 and a user interface 200 for reducing a bio-potential of a target site of a user.

The treatment apparatus 100 may be provided with at least one of the first target bioelectrical potential, the time lapse per second, the charge time, the discharge time, the capacitor selection information, and the switching speed, based on the operation information and the control information received from the user interface 200 You can do one. A more detailed description will be given later.

The treatment apparatus 100 may perform wireless communication between the user interface 200 and the treatment apparatus 100 via the wireless communication may include operation information for driving the treatment apparatus 100 from the user interface 170, Lt; / RTI >

Examples of wireless communications performed between the user interface 200 include a third generation partnership project (3GPP) network, a long term evolution (LTE) network, a world interoperability for microwave access (WIMAX) Internet, a LAN, a WLAN, a PAN, a Bluetooth network, a satellite broadcasting network, an analog broadcasting network, a DMB (Digital Multimedia Broadcasting) Multimedia Broadcasting) network, and the like, but is not limited thereto.

In FIG. 1, the treatment system is illustrated as including only one treatment apparatus 100, but the present invention is not limited thereto, and may include a plurality of pain treatment apparatuses.

In addition, the plurality of treatment apparatuses 100 may be configured such that, based on the operation information and the selection information received from the user interface 200, at least some of the plurality of treatment apparatuses 100 and the remaining part of the apparatuses have different operation information and / Can be controlled to have the type of selection information.

Hereinafter, the treatment apparatus 100 will be described in more detail with reference to FIG. 2 to FIG.

FIG. 2 is a block diagram schematically showing a configuration of a treatment apparatus according to an embodiment of the present invention, and FIG. 3 is a view for explaining a relationship between a capacitor and a resistance at a target site or a non-target site according to an embodiment of the present invention FIG. 4 is a view for explaining charging and discharging of a bioelectrical charge in the bioelectrical potential decreasing part according to an embodiment of the present invention, and FIG. 5 is a schematic view showing the operation of the treatment device according to one embodiment of the present invention FIG. 8 is a graphical representation showing the progress of the reduction of the bioelectrical potential of the target site according to the embodiment of the present invention.

Referring to FIG. 2, the treatment apparatus 100 may include an electrode 110, a bio-potential reduction unit 120, and a control unit 130.

The electrode 110 may be attached to the body surface of the target site. The electrode 110 is attached to the skin surface of the user to receive the bioelectrical charge. The target site may include, but is not limited to, a menstrual aortic area, a tender point, a lesion, a major hemorrhage, a lesion, and the like.

Referring to FIG. 3, when the subject C1 and the menstrual-atrophic area are compared with the non-target areas C2 and C3, Non-acupuncture site), where the resistance is low and the potential and capacity are high, can be the subject site (C1, meridian area). For example, there is a region of the human body that has low resistance and high potential, and certain cell groups may exist in this region. This particular cell group has a variable cell membrane potential and has a special structure and function. The fluctuating cell membrane potential is the amount of bioelectrical charge, and the place where the amount of the bioelectrode charge is large may be a target site (for example, a meridian point) or a nerve point site. That is, since the cell membrane potential is actively moved relative to the non-target site (for example, the non-target site) (for example, the non-target site), the capacitance component value is large while the resistance component value is small. By comparing and analyzing the capacitance values of specific target regions of the human body, the position of the target region (for example, the acupoint) can be confirmed.

The electrode 110 may be a rod-shaped, whole-body, contact-type bioelectrode, but is not limited thereto. The electrode 100 can be brought into direct contact with the body surface (e.g., skin) of the target site (e.g., the acupoint) to receive the bioelectrical charge. At this time, since the ionic charge of the living body itself is received, it is not necessary to apply a separate voltage or current to the human body.

The bioelectric potential reduction unit 120 can reduce the bioelectric potential of the target site. It may be that the amount of ions distributed at the target site is reduced due to the reduction of the bioelectric potential.

The biotissue reduction unit 120 can generate a first potential difference associated with the first living body potential by charging and discharging the electric charge in the first time interval. In addition, the vital sign reduction unit 120 can generate a second potential difference related to the second living body potential by charging and discharging the electric charge at the second time interval. For example, the time interval may be a set time stored in the vital capacity reduction unit 120. As another example, the time interval may be a set time interval input from the user interface. The biotissue reduction unit 120 can generate a first potential difference related to the first bioelectrical potential by setting a first time interval (for example, one minute) and charging and discharging the bioelectrical charge on the target site. For example, the first potential difference may be the potential difference of the capacitor 122 in which the bio-ion charge is charged and discharged.

At this time, the second time interval may be a time interval after the first time interval, and the second potential difference may be smaller than the first potential difference.

According to one embodiment of the present invention, the treatment apparatus 100 receives an electric charge from an electrode 110 attached to a body surface of a target site (e.g., a site of acupoint) The potential of the site can be reduced by decreasing the potential. The vital sign reduction unit 120 generates the second potential difference after the first potential difference. The living body potential decreasing unit 120 can reduce the living body potential by charging and discharging the living body potential of the target site before driving the treatment apparatus 100 when generating the first potential difference.

In addition, the vital sign reduction unit 120 can generate a third potential difference related to the third living body potential by charging and discharging the electric charge in the third time interval.

The first time interval corresponds to a first rotation, the second time interval corresponds to N rotation, N is a natural number greater than 1, the third time interval corresponds to M rotation, M is a natural number greater than N, Lt; / RTI >

According to one embodiment of the present application, the first time interval corresponds to one time (e.g., once), the second time interval corresponds to N times (e.g., 10 times), the third time interval corresponds to M (for example, 20 times). The biotissue reduction unit 120 can generate a potential difference corresponding to each of the times 20 times (for example, 20 minutes) at intervals of one minute.

According to one embodiment of the present invention, the third potential difference associated with the third living body potential of the living body potential decreasing section 120 may be equal to the second potential difference associated with the second living body potential. For example, the bio-potential reduction unit 120 can continuously reduce the bio-potential at a target site (for example, a meridian point) at intervals of one minute. The biotissue reduction unit 120 can generate a potential difference having the same bioelectric potential by receiving the charge of the target site. That is, the second potential difference and the third potential difference are the same, but the capacitor 121 of the target site (for example, the acupoint) may be saturated, but the present invention is not limited thereto.

The biotissue reduction unit 120 can reduce the first vital potential to the first target vital potential of the first target site by charging and discharging N turns to the first target site. Illustratively, the first object site may be a site corresponding to the menstrual cycle of the human body. The bio-potential reduction unit 120 charges and discharges the first target site N times (for example, 20 times) to the first target site, which is one of the meridians, to convert the first bio- 1 target site) of the first target organism. The target bio-potential may be a saturation value, but is not limited thereto. For example, the target bio-potential may be a target bio-potential value set in the bio-potential reduction unit 120. That is, depending on the target site (for example, the acupuncture point), the target bio-potential may be set differently by the bio-potential reduction unit 120 or may be determined by the user's input. The target vital potential may be the potential difference of the target site, but it is not limited thereto, but it may be another potential difference between the capacitors.

The biotissue reduction unit 120 may charge and discharge the M-times charge when the target site is the second target site, thereby reducing the second biotage potential of the second target site to the second target biotope potential of the second target site have. However, M is greater than 1 and may be a natural number different from N. For example, when the second target site is a triplet, which is one of the meridians, charging and discharging M times (for example, 15 times), the second biomedical potential of the second target site (triplet) (Triplet) to the second target vital potential. And the amount of charge and discharge of the charge of each of the first object site and the second object site may be different from the target bioelectric potential value. For example, the first target site (rootstock) can be reduced to the first target biotissue only by 10 times, but the second target site (triplet) can not be reduced to the second target biotope even by only 10 times, To be able to reach the second target living body potential.

Illustratively, referring to Fig. 8, it is possible to confirm the value of the bioelectrical potential of the target site measured in the operating cycle corresponding to the time interval at the target site (for example, the acupoint). The first time interval corresponding to the first time interval and the 10th time interval corresponding to the second time interval indicate that the target portion corresponding to the 10th time interval of the second time interval existing after the first time interval The acupuncture point), the bio-potential of the blood vessel is decreased. According to one embodiment of the present invention, the graph of Fig. 8 shows the progress of decreasing the bio-potential of the target site for 20 times (20 minutes) at 1 minute intervals. By reducing the bioelectric potential of the target site, it can be seen that the disease treatment effect is obtained. Illustratively, in FIG. 8, it can be confirmed that the first target bioelectrical potential at the first target site has decreased to the target target biochemical potential by charging and discharging charges ten times. The target vital potential may be information input by the information of the target site, but is not limited thereto, and may be a value set based on input information of the target target vital potential of the user.

The input unit (not shown) may receive selection information of the first target site or the second target site through a user interface. The control unit 130 can control the operation of the living body potential decreasing unit 120 based on the selection information. At this time, the selection information may include at least one of information on N, information on M, a first target vital potential and a second target vital potential.

For example, the user may enter information about the first target site through the user interface. The control unit 130 may generate the number of times information on the charge and discharge of the first target site and the control information of the first target living body potential to control the operation of the living body potential reduction unit 120.

In addition, the input unit (not shown) receives the selection information of the first target site through the user interface, the control unit 130 determines the operation information based on the selection information, and controls the operation of the living body potential reducing unit Can be controlled. Also, the control unit 130 can determine the operation information based on the user's selection information, and can control the operation of the living body potential decreasing unit based on the operation information.

The operation information may include at least one of information about N, a first target vital potential, a time interval per one time, a charge time, a discharge time, a capacitor selection information, and a switching speed.

The selection information may include at least one of target site information, information about N, a first target bioelectrical potential, a time interval per one time, a charge time, a discharge time, a capacitor selection information, and a switching speed.

According to one embodiment of the present invention, an input to a target site can be provided through a user interface. The input unit (not shown) receives information indicating that the information of the target site is acupuncture blood in the acupuncture point, receives information (for example, 20 times) about N to perform charging and discharging for the blood, At least one of the time interval (for example, one minute), the charge time (for example, one second), the discharge time (for example, one second), the capacitor selection information and the switching speed You can enter one.

For example, when only the information on the target site is input, the bio-potential decreasing unit 120 can determine the target site information using the preset values and reduce the target site bio-potential. That is, the bio-potential reduction unit 120 may include operation information corresponding to each target site (menstrual discharge), and may control the bio-potential reduction unit 120 based on user's selection information from the control unit 130 .

Referring to FIG. 4, the bio-potential reduction unit 120 may include a switching unit 121, a capacitor 122, and a discharging unit 123.

The switching unit 121 may switch ON or OFF of the connection between the electrode and the capacitor. The switching speed of the switching unit 121 may be controlled based on information input by a user, but is not limited thereto. The speed of the switching unit 121 can be controlled based on the switching speed information of each target part set in the living body potential decreasing unit 121. [ The bioelectrical charge can be charged and discharged according to the speed of the switching unit 121. [ The switching unit 121 can turn on the circuit when charging the electric charge and open the circuit completely when discharging to prevent the reverse current.

The capacitor 122 can be charged by receiving charge through the electrode when the connection is on. The capacitor 122 may be a variable capacitor. The capacitance of the variable capacitor can be determined based on the control signal of the control unit. The variable capacitor can be varied within a range of .1uF to 0.33uF.

The discharge unit 123 can discharge the charge of the charged capacitor when the connection is off.

The bioelectrical potential reduction part 120 can be simplified for explanation with the capacitor 122 and the discharge part 123. [ The discharging unit 123 may include a transistor Tr. The transistor Tr may be one for discharging the charging charge of the capacitor, but the present invention is not limited thereto. For example, the transistor Tr may be a discharging element. The emitter of the transistor Tr is grounded, and the collector of the transistor Tr is connected to the electrode so as to receive the bioelectrical charge. The charge and discharge capacitor Csystem is connected between the collector and the emitter of the transistor Tr, uses a variable capacitor, and can use 0.1 uF to 0.33 uF. That is, the charge and discharge capacitor (Csystem) can use a variable capacitor varying from 0.1 uF to 0.33 Uf.

The control unit 130 generates an operation signal for driving the transistor Tr of the living body potential decreasing unit 120 and outputs the operation signal to the transistor Tr of the living body potential decreasing unit 120 in accordance with the operation control signal received from the operation processing unit ).

The bioelectrical charge is inputted by the electrode 110 which is in contact with the body surface of the target site and is charged into the capacitor 122. [ Charging and discharging of the charging and discharging capacitors 122 and Csystem are controlled in accordance with the operation signal of the living body potential decreasing section 120, that is, the input signal of the base of the transistor Tr of the living body potential decreasing section 120. That is, the charge of the capacitor 122 (Csystem) can be discharged by the transistor Tr.

By receiving the charge through the electrode 110 that is in contact with the body surface of the target site, the bioelectric potential of the target site can be reduced. When the connection between the electrode 110 and the capacitor 122 is switched on or off in the switching unit 121 and the connection is turned on by the capacitor 122, the charge is received through the electrode, (Not shown). The charge of the capacitor 122 charged in the discharge part 123 can be discharged when the switching part 121 is off. Charging and discharging are repeated according to whether the switching unit 121 is on or off, and the living body potential of the target site can be reduced.

The detected potential of the capacitor 122 is amplified by a signal preprocessing unit (not shown), noise is removed, and is transmitted to an operation processing unit (not shown) through an A / D conversion unit (not shown).

The arithmetic processing unit (not shown) outputs the received living body potential, and also outputs a reference value at this time. The user relatively identifies the current bioelectric potential with its relative vehicle. The arithmetic processing unit (not shown) can determine the target region (for example, the acupoint) through calculation processing from the received bioelectrical potential and output the result through the user interface 200 or the like.

The bioelectric potential of the capacitor 122 may be proportional to the amount of the bioelectrical charge in the target site (for example, the menstrual blood) or the non-target site (for example, non-menstrual blood). The potential at both ends of the capacitor 122, that is, the bioelectric potential, can be defined by the following equation (1).

[Equation 1] V1 = q / c

Here, V1 is the bioelectrical potential, that is, the charging and discharging potential, q is the bioelectrical charge amount, and c is the capacitance. Therefore, the living body potential V1 is proportional to the bioelectrical charge q. The base of the transistor Tr of the vital sign reduction unit 120 receives a pulse signal that repeats '1' and '0'. When the input signal of the base of the transistor Tr of the living body potential decreasing part 120 is inputted as '1', the transistor Tr is turned on and the charged biomolecule charge of the capacitor 122 is discharged. When '0' is input to the input signal of the base of the transistor Tr of the vital sign reduction unit 120, the transistor Tr is turned off and the capacitor 122 is charged with the biomedical charge.

Referring to FIG. 5, the target site may be (C) meridian on meridians, but the present invention is not limited thereto. The target site may be a target site having a bioelectrical potential, and the size of the bioelectrical potential may be proportional to the bioelectrical charge of the target site. The capacitor 122 may be a capacitor 122 for discharging and charging biological charges of a target site as an external electronic device. Since the capacitor 122 is larger than the charging and discharging capacitor 122 at the target site, the capacitor 122 instantaneously charges and discharges the charged electric charge in the target site in accordance with the control signal of the controller 130, It can be proportional to the size of the target site.

The bio-potential reduction unit 120 can reduce the bio-ionic charge at the acupuncture point or the measurement site through the very small capacitor 122 to the outside. The ion charge can be instantaneously transferred from the target portion C1 to the capacitor 122 due to the relationship of the target portion C1 and the capacitor 122. [ The amount of charge in each of the capacitors 122 represents the energy level at the measurement site, and charging and discharging are controlled by the control signal of the control unit 130 repeatedly. That is, when the switch of the switching unit 121 is turned on by the control signal, the bioelectrical charge is charged from the menstrual blood into the capacitor 122 to generate the charging potential, and when the switch of the switching unit 121 is turned off The charge stored in the capacitor 122 is discharged through the discharge portion 123, so that a discharge potential is generated. The charge and discharge potential value of the capacitor 122 is proportional to the amount of the bioelectrical charge at the measured site.

According to one embodiment of the present invention, a disease-related numerical value detection unit (not shown) can detect a disease-related value of a subject. For example, disease control values may be information corresponding to hypertension values, blood pressure monitors, and the like. The disease control numerical detection unit can confirm the progress of the disease by reducing the bioelectric potential of the target site.

The disease management numeric detection unit can detect that the second disease related value detected after the second time interval is different from the first disease related value detected after the first time interval.

For example, the electrode 110 may be attached to the acupuncture point of the hypertensive patients and the bioelectric potential reduction unit 120 may reduce the bioelectric potential of the three-way bridge and the triplet bridge. The disease-related numerical detection unit can detect the systolic blood pressure and the diastolic blood pressure of the hypertensive patient after the reduction of the bioelectric potential of the target site. The disease-related numerical value detection unit can compare the numerical information before and after the treatment apparatus 100.

Illustratively, referring to FIG. 7, the detection result of the disease-related numerical-value detection unit can obtain information as shown in FIGS. 7A and 7B. Fig. 7 (a) represents the change in the capacitor voltage at the target site, and may be a change in the bioelectric potential at the target site. 7 (b) shows that there is a change in the blood pressure by decreasing the bioelectrical potential at the target site as a change in the blood pressure with time. As shown in Fig. 7 (b), it can be confirmed that the systolic blood pressure at the reference point is 147 (mmHg) and the minimum blood pressure at 98 is (mmHg), and the first disease- The systolic blood pressure was 143 mmHg, the minimum blood pressure was 88.5 mmHg, the second sickness-related blood pressure was 138 mmHg after the second time interval (30 minutes) 85 (mmHg). That is, it can be confirmed that the second disease-related value detected after the second time interval is smaller than the first disease-related value detected after the first time interval.

The electrode 110 is attached to the body surface of the target site to receive the charge, and the bioelectric potential reduction unit 120 can reduce the bioelectric potential of the target site. The control unit 130 may control the operation of the living body potential reducing unit 120. [

The signal processing unit (not shown) can remove noise by amplifying the bioelectric potential signal received from the bioelectric potential reduction unit. The signal processing unit (not shown) may include an amplification unit and a filter unit. The amplifying unit can amplify the bioelectric potential signal received from the bioelectrical potential decreasing unit (not shown). The filter unit may remove power supply noise and the like from the output signal of the amplifying unit and transmit the same to an A / D converting unit (not shown). The signal processing unit (not shown) may include a rectifying unit of the filter unit. The rectification section converts the amplified and noise-free signal into a DC signal. The signal that has passed through the amplifying unit or the like includes a ripple signal, which is a kind of a crossing signal, which is rectified and converted into a DC signal and sent to an A / D converter (not shown).

The A / D conversion unit (not shown) converts the bio-potential signal received by the signal preprocessing unit (not shown) into a digital signal and transmits the digital signal to an arithmetic processing unit (not shown).

The arithmetic processing unit (not shown) performs arithmetic processing on the living body potential signal received from the A / D converter (not shown) to determine whether it is menstrual or non-menstrual. An operation processing unit (not shown) can output the signal received from the A / D conversion unit (not shown) to the user interface 200.

For example, an arithmetic processing unit (not shown) can output an alarm notifying that it is a menstrual blood when the arithmetic processing result is menstrual blood. The operation processing unit (not shown) receives the setting signal of the input information capacity setting signal, mode setting signal, and the like transmitted from the user interface, generates the biological control signal, and transmits the biological control signal to the control unit 130 through the D / A converter . The arithmetic processing unit (not shown) is formed of a microprocessor, and can be constructed of, for example, a PIC16C74 manufactured by Micrichips.

According to one embodiment of the present invention, the control unit 130 can determine the operation information of the vital sign reduction unit 120 based on the determination result of whether the arithmetic processing result of the arithmetic processing unit (not shown) is menorrhagic or non-acellular.

The acupuncture point of the user is obtained by judging the menstrual blood and the non-acupuncture point by the calculation processing result of the calculation processing unit (not shown) And controls the operation of the living body potential decreasing section 120 based on the operation information.

In addition, the arithmetic processing unit (not shown) can determine whether or not at least one arithmetic processing result among a plurality of target regions is menstrual blood. The control unit 130 may generate a control signal and transmit the control signal to the switching unit 121 when at least one operation processing unit (not shown) of the plurality of target sites has a calculation result of a menstrual discharge. That is, the calculation processing unit (not shown) can determine that only the first target site, the second target site, and the third target site among the first to sixth target sites are acupuncture points. The control unit 130 can control the operation of the bio-potential reduction unit 120 so as to receive charges through the electrodes attached to the first target site, the second target site, and the third target site. The biotissue reduction unit 120 may reduce only the bioelectric potential of the first to third target sites determined to be menstrual blood. The arithmetic processing unit (not shown) can provide, through the user interface, that the fourth target site, the fifth target site, and the sixth target site are not menstrual blood.

6 is a view showing an example of a case where a plurality of treatment apparatuses according to an embodiment of the present application are provided.

Referring to FIG. 6, a treatment device 100 according to an embodiment of the present invention may include a plurality of treatment devices 111, 112, 113, 114, 115, and 116. Each of the plurality of treatment devices 111, 112, 113, 114, 115, and 116 may perform the same function as the treatment device 100 described above.

The control unit 130 according to an embodiment of the present invention can simultaneously control a plurality of treatment devices 111, 112, 113, 114, 115, and 116 in multiple channels. Each of the plurality of treatment devices 111, 112, 113, 114, 115, and 116 may be controlled wirelessly based on the control command information received from the user interface 200. [

In addition, according to another embodiment of the present application, the channels of each of the plurality of treatment devices 111, 112, 113, 114, 115, and 116 may be bundled into wires or the like, an on / off control unit may be separately provided.

The plurality of treatment apparatuses 111, 112, 113, 114, 115, and 116 may be attached to the back of the abdomen, the abdomen, or the legs.

The input unit may receive control command information for operating the plurality of therapeutic apparatuses 111, 112, 113, 114, 115, and 116 from the user interface, and may input the received control command information to the plurality of therapeutic apparatuses 111, 112, 113, 114, 115, and 116, respectively.

Each of the plurality of treatment devices 111, 112, 113, 114, 115, and 116 may control operation information on each of them. The plurality of therapeutic apparatuses 111, 112, 113, 114, 115, and 116 may be configured to perform a plurality of treatment apparatuses 111, 112, 113, 114, 115, 112, 113, 114, and 114 so that the pain treating apparatus has different charging and discharging times, time intervals, charging time, discharging time, capacitor selecting information, and switching speed different from those of the second pain treating apparatus. 115, and 116, respectively.

For example, the plurality of treatment apparatuses 111, 112, 113, 114, 115, and 116 may include a first pain therapy apparatus 111, 112 and a second pain therapy apparatus 113, 114, (115, 116). The grouping of such treatment apparatuses is only one embodiment for explaining the present invention, and the present invention is not limited thereto but can be modified in various ways. The grouping of such therapeutic devices can be divided into groups in order to provide the same operation information when symmetrically formed target sites (for example, acupoints) are located.

FIG. 7 is a diagram illustrating an example in which the results of a treatment apparatus according to an embodiment of the present invention are dataized and provided to a user

The data generating unit (not shown) can generate bio-ion charge amount information of a target site measured for a predetermined time. The data generating unit (not shown) may graph the biochar amount of the ions for a predetermined time and provide the data to the user.

Referring to FIG. 7, the data generator (not shown) may provide the user's terminal with the bio-ion charge change value of the target site measured as shown in FIG. 7 (a). FIG. 7 (b) shows the detection change value of the disease-related numerical value detection unit of the subject, and it can be confirmed that the change of the disease-related numerical value is also detected by the change of the bioelectric charge amount change value.

Although the drawings are not separately described, in one embodiment of the present invention, a treatment method for reducing a bioelectrical potential of a target site is a treatment method for reducing a bioelectrical potential of a target site. The treatment method includes receiving charges through electrodes attached to a body surface of a target site Thereby reducing the vital potential of the target site. Further, the step of reducing the bioelectrical potential of the target site may include switching the ON or OFF of the connection between the electrode and the capacitor in the switching unit, switching the ON or OFF state of the connection between the electrode and the capacitor in the switching unit, Charging by accepting; Discharging the charge of the charged capacitor when the connection is turned off at the discharging part, and controlling the operation of the living body potential reducing part at the controlling part. Such a therapeutic method for reducing the vital potential may be performed by the treatment device or its parts that reduces the vital potential described above. Therefore, contents which have not been described for the treatment method for reducing the vital potential through the separate drawings or explanation are applied mutatis mutandis to the description about the treatment device for reducing the vital potential.

In addition, the treatment method for reducing the vital potential described above can also be implemented in the form of a recording medium including instructions executable by a computer, such as a program module executed by a computer. Computer readable media can be any available media that can be accessed by a computer and includes both volatile and nonvolatile media, removable and non-removable media. In addition, the computer-readable medium may include both computer storage media and communication media. Computer storage media includes both volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data. Communication media typically includes any information delivery media, including computer readable instructions, data structures, program modules, or other data in a modulated data signal such as a carrier wave, or other transport mechanism.

In addition, the above-described treatment method for reducing the vital potential can be also implemented in the form of a computer program stored in a recording medium.

It will be understood by those of ordinary skill in the art that the foregoing description of the embodiments is for illustrative purposes and that those skilled in the art can easily modify the invention without departing from the spirit or essential characteristics thereof. It is therefore to be understood that the above-described embodiments are illustrative in all aspects and not restrictive. For example, each component described as a single entity may be distributed and implemented, and components described as being distributed may also be implemented in a combined form.

The scope of the present invention is defined by the appended claims rather than the detailed description, and all changes or modifications derived from the meaning and scope of the claims and their equivalents should be interpreted as being included in the scope of the present invention.

100: Therapeutic device
110: electrode
120: bioelectrical potential reduction part
121:
122: Capacitor
123: Discharge
130:
200: User interface

Claims (23)

A treatment device for reducing a vital potential of a target site,
An electrode attached to a body surface of a target site; And
A bioelectrical potential decreasing unit for receiving a charge through the electrode to reduce the bioelectrical potential of the target site;
≪ / RTI > The method according to claim 1,
Wherein the bio-
Generating a first potential difference associated with the first vital potential by charging and discharging the charge at a first time interval,
Generating a second potential difference associated with the second vital potential by charging and discharging the charge at a second time interval,
Wherein the second time interval is a time interval after the first time interval,
And the second potential difference is smaller than the first potential difference. 3. The method of claim 2,
A disease-related numerical value detection unit for detecting a disease-related numerical value of a subject,
Wherein the second disease-related value detected after the second time interval is different from the first disease-related value detected after the first time interval. 3. The method of claim 2,
Generating a third potential difference associated with the third vital potential by charging and discharging the charge at a third time interval,
Wherein the first time interval corresponds to a first time interval, the second time interval corresponds to N times (where N is a natural number greater than 1), the third time interval corresponds to M times (where M is a natural number greater than N ),
And the third potential difference is equal to the second potential difference. The method according to claim 1,
Wherein the target site is a first target site, the vital potential is a first biota potential,
Wherein the bio-
Wherein the charge is charged and discharged N times (where N is a natural number greater than 1) to reduce the first vital potential to a first target vital potential of the first target site. 6. The method of claim 5,
Wherein the bio-
When the target site is the second target site, charges are discharged and discharged by M times (where M is a natural number different from N and a natural number different from N) to thereby transfer the second biomedical potential of the second target site to the second target To the second target vital potential of the site. The method according to claim 6,
An input unit for receiving selection information of the first target site or the second target site through a user interface; And
Further comprising a control section for controlling the operation of the living body potential decreasing section based on the selection information. 8. The method of claim 7,
Wherein the selection information includes at least one of the information on N, the information on M, the first target vital potential and the second target vital potential. 6. The method of claim 5,
An input unit for receiving selection information through a user interface; And
Further comprising a control section for controlling the operation of the living body potential decreasing section based on the selection information. 10. The method of claim 9,
Wherein the input unit receives the selection information of the first target region through a user interface,
Wherein the control section determines the operation information based on the selection information and controls the operation of the living body potential decreasing section based on the operation information. 10. The method of claim 9,
Wherein the operation information includes at least one of the information on N, the first target bioelectrical potential, the time interval per one time, the charge time, the discharge time, the capacitor selection information, and the switching speed. 10. The method of claim 9,
Wherein the selection information includes at least one of target site information, information on the N, the first target bioelectrical potential, a time interval per one time, a charge time, a discharge time, a capacitor selection information, and a switching rate. The method according to claim 1,
Wherein the bio-
A switching unit switching ON or OFF of a connection between the electrode and the capacitor;
A capacitor charged by receiving charge through the electrode when the connection is turned on; And
And a discharge unit for discharging the charge of the charged capacitor when the connection is turned off,
Wherein the treatment apparatus further comprises a control section for controlling the operation of the vital sign reduction section. The method according to claim 1,
Wherein the amount of ions in the target site is reduced due to the reduction of the vital potential. 14. The method of claim 13,
The capacitor is a variable capacitor,
And the capacitance of the variable capacitor is determined based on a control signal of the control unit. 16. The method of claim 15,
Wherein the variable capacitor is variable within a range of 0.1 uF to 0.33 uF. The method according to claim 1,
A signal preprocessing unit for amplifying the bioelectric potential signal received from the bioelectrical potential decreasing unit to remove noise;
An A / D conversion unit for converting the bioelectric potential signal received from the signal preprocessing unit into a digital signal; And
Further comprising an arithmetic processing unit for arithmetically processing the bioelectric potential signal received from the A / D converter to determine whether it is menstrual or non-acupuncture. 18. The method of claim 17,
Wherein,
Based on the judgment result of the menstrual flow and the non-acupuncture in the calculation processing section, the operation information of the living body potential decreasing section is determined, and the operation of the living body potential decreasing section is controlled based on the operation information. 18. The method of claim 17,
The control unit
Wherein when a calculation result of at least one of the plurality of target portions is a menstrual blood, a control signal is generated and transmitted to the switching unit. The method according to claim 1,
And a housing formed to be attachable to the body of the user. The method according to claim 1,
The plurality of electrodes are attached to the body surface of the target site,
Wherein,
Determines the operation information for each of the plurality of electrodes, and controls the operation of the living body potential decreasing section based on the operation information. The method according to claim 1,
Further comprising: a data generating unit generating the bio-potential information of a target site measured for a predetermined time,
Wherein the data generation unit graphs the bio-potential information for the predetermined time and provides the bio-potential information to a user. 23. The method of claim 22,
Further comprising a transmitter for transmitting the bio-potential change value of the data generator to the user's terminal.

Images